In recent years, the Internet has played a subordinate role in the healthcare sector. However, thanks to Web 2.0, e-health is on the rise again and also offers scope for new, innovative projects in Switzerland. The market potential is correspondingly large, with disease-specific e-health models in particular promising success.
Thanks to the strong presence of several leading international pharmaceutical and medtech companies in Switzerland, the areas of diabetes, cardiovascular diseases, oncology, dentistry, orthopaedics, etc. are particularly suitable for specific solutions. Cooperation with competent, complementary partners who may contribute medical, nursing or technical expertise or facilitate access to customers is also essential in the design of the offering. In the field of diabetes, partnerships with pharmaceutical companies such as Roche or Novo Nordisk or with medtech manufacturers such as Medtronic, Ypsomed or LifeWatch / Card Guard make sense. Premium offers can also be piloted and established in cooperation with health insurance companies. Such disease-specific and needs-oriented models developed in partnership have the potential to establish themselves on the international market thanks to their “Swissness”.
